Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Yichu Yuan"'
Autor:
Ruopeng Su, Zeyu Chen, Daoping Hong, Shuai Jiang, Yichu Yuan, Xingyun Cai, Hailong Hu, Changde Fu, Zhiyang Huang, Zhenyu Wang, Bing Zheng, Jian Huang, Zaoyu Wang, Yige Bao, Ming Cai, Jianming Guo, Minfeng Chen, Qiang Wei, Jiwei Huang, Wei Xue
Publikováno v:
Cancer Medicine, Vol 12, Iss 9, Pp 10587-10596 (2023)
Abstract Introduction The effectiveness and safety of immune checkpoint inhibitor (ICI) monotherapy in advanced upper tract urothelial carcinoma (UTUC) is less reported. Methods In total, 106 consecutive advanced UTUC patients receiving ICI monothera
Externí odkaz:
https://doaj.org/article/c3876d197ec547c980452d1c1b9c9eae
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
RationalePrimary renal parenchymal squamous cell carcinoma (SCC) is an extremely rare tumor that is difficult to diagnose by hematology and imaging studies and is often diagnosed later than other primary renal cancers.DiagnosisA 52-year-old male pati
Externí odkaz:
https://doaj.org/article/ec47b62959984f30a60814d0f0f69e4c
Autor:
Jiwei Huang, Yueming Wang, Haoran Zhang, Xiaoyi Hu, Ping Wang, Wen Cai, Yichu Yuan, Hao Zeng, Jin Zhang, Wen Kong, Yiran Huang, Shuo Wang, Jianming Guo, Qiang Wei, Wei Xue
Publikováno v:
Cancer Communications, Vol 41, Iss 10, Pp 1071-1074 (2021)
Externí odkaz:
https://doaj.org/article/40886ad3db8748f68a31f4491bec8a64
Autor:
Jiwei Huang, Ruopeng Su, Zeyu Chen, Shuai Jiang, Minfeng Chen, Yichu Yuan, Hailong Hu, Changde Fu, Zhiyang Huang, Zhenyu Wang, Bing Zheng, Chancan Li, Zaoyu Wang, Yige Bao, Ming Cai, Jianming Guo, Qiang Wei, Wei Xue
Publikováno v:
OncoImmunology, Vol 11, Iss 1 (2022)
Although several programmed cell death (PD)-1 inhibitors are approved for the first-line treatment of advanced urothelial carcinoma, their efficacy remains unknown in cisplatin-ineligible patients with upper tract urothelial carcinoma (UTUC) compared
Externí odkaz:
https://doaj.org/article/1bb537d63a744684b3f442e300063de3
Autor:
Jiwei Huang, Hongyang Qian, Yichu Yuan, Xingyun Cai, Yonghui Chen, Jin Zhang, Wen Kong, Xiaorong Wu, Ming Cao, Yiran Huang, Haige Chen, Wei Xue
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
PurposeTo determine the safety and feasibility of extraperitoneal laparoscopic extended lymph node dissection (LND) at the time of extraperitoneal laparoscopic radical nephroureterectomy (RNU).Materials and MethodsBetween May 2018 and March 2019, 39
Externí odkaz:
https://doaj.org/article/baa8805221ba4e91be9031864230d42c
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
IntroductionAs a research team of urologists and an anesthetist, we sought to investigate the prognostic significance of American Society of Anesthesiologists (ASA) score in patients with upper tract urothelial cancer (UTUC) after radical nephrourete
Externí odkaz:
https://doaj.org/article/67ac193d0b224ffb874329eb0d2e5075
Autor:
Weimin Zhong, Yinan Li, Yichu Yuan, Hongbin Zhong, Chaoqun Huang, Jiwei Huang, Yao Lin, Jiyi Huang
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Clear cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer and has strong immunogenicity. A systematically investigation of the tumor microenvironment (TME) in ccRCC could contribute to help clinicians develop personalized treat
Externí odkaz:
https://doaj.org/article/ea584dc4b04d4247a22f68c5e4a3b152
Publikováno v:
PLoS ONE, Vol 15, Iss 5, p e0227844 (2020)
Morroniside is a biologically active polyphenol found in Cornus officinalis Sieb. et Zucc (CO) that exhibits a broad spectrum of pharmacological activities, such as protecting nerves, and preventing diabetic liver damage and renal damage. However, li
Externí odkaz:
https://doaj.org/article/c9ad6bc6f48745ce8e9a45e1f1cc90df
Autor:
Shi-Geng Zhang, Yichu Yuan, Shi-Yi Shao, Xiao-Fang Xia, Nan Zhang, Xin-Yu Zhao, Zhong-Yi Li, Yi-Qiu Wang
Publikováno v:
BMC Urology, Vol 22, Iss 1, Pp 1-13 (2022)
BMC Urology
BMC Urology
Objectives To describe the influence of the socioeconomic development on worldwide age-standardized incidence and mortality rates, as well as mortality-to-incidence ratio (MIR) and 5-year net survival of urologic cancer patients in recent years. Meth
Autor:
Xiaoyi Hu, Wen Kong, Haoran Zhang, Yiran Huang, Hao Zeng, Wen Cai, Jianming Guo, Wei Xue, Jin Zhang, Shuo Wang, Yichu Yuan, Yueming Wang, Ping Wang, Jiwei Huang, Qiang Wei
Publikováno v:
Cancer Communications, Vol 41, Iss 10, Pp 1071-1074 (2021)
Cancer Communications
Cancer Communications